|
|
histone h3 k9 methylation
|
GO:0051567 |
17 |
1.000
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.999
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.999
|
|
|
|
positive regulation of histone h3 k27 methylation
|
GO:0061087 |
4 |
0.998
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.998
|
|
|
|
regulation of histone methylation
|
GO:0031060 |
30 |
0.997
|
|
|
|
positive regulation of histone h3 k9 methylation
|
GO:0051574 |
4 |
0.995
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.994
|
|
|
|
negative regulation of histone methylation
|
GO:0031061 |
10 |
0.993
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.991
|
|
|
|
dna modification
|
GO:0006304 |
50 |
0.987
|
|
|
|
positive regulation of histone methylation
|
GO:0031062 |
16 |
0.987
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.985
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.983
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.982
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.979
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.975
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.972
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.971
|
|
|
|
dna methylation involved in gamete generation
|
GO:0043046 |
15 |
0.970
|
|
|
|
negative regulation of chromosome organization
|
GO:2001251 |
30 |
0.966
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.954
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.948
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.947
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.945
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.938
|
|
|
|
dna methylation
|
GO:0006306 |
43 |
0.938
|
|
|
|
positive regulation of chromatin modification
|
GO:1903310 |
28 |
0.932
|
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
33 |
0.931
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.925
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.923
|
|
|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.922
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.916
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.914
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.904
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.900
|
|
|
|
regulation of histone h3 k9 methylation
|
GO:0051570 |
8 |
0.899
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.894
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.893
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.891
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.849
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.809
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.807
|
|
|
|
dna alkylation
|
GO:0006305 |
43 |
0.795
|
|
|
|
male meiosis i
|
GO:0007141 |
16 |
0.784
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.781
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.770
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.754
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.750
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.726
|
|
|
|
histone h3 k9 acetylation
|
GO:0043970 |
5 |
0.719
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.718
|
|
|
|
regulation of histone h3 k27 methylation
|
GO:0061085 |
6 |
0.707
|
|
|
|
chromatin silencing
|
GO:0006342 |
15 |
0.701
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.696
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
28 |
0.690
|
|
|
|
genetic imprinting
|
GO:0071514 |
27 |
0.685
|
|
|
|
chromatin assembly
|
GO:0031497 |
13 |
0.684
|
|
|
|
cytokinesis
|
GO:0000910 |
17 |
0.659
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.653
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.639
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.609
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.594
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.576
|
|
|
|
histone h3 k27 methylation
|
GO:0070734 |
11 |
0.575
|
|
|
|
positive regulation of histone h3 k4 methylation
|
GO:0051571 |
5 |
0.560
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.558
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.540
|
|
|
|
positive regulation of histone modification
|
GO:0031058 |
28 |
0.535
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.535
|
|
|
|
male meiosis
|
GO:0007140 |
37 |
0.518
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.502
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.493
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.484
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.482
|
|
|
|
negative regulation of chromatin modification
|
GO:1903309 |
19 |
0.475
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.471
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.457
|
|
|
|
dna packaging
|
GO:0006323 |
30 |
0.443
|
|
|
|
negative regulation of gene expression epigenetic
|
GO:0045814 |
15 |
0.434
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.417
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.411
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
35 |
0.405
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.395
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.392
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.378
|
Fly |
|
|
digestive system development
|
GO:0055123 |
200 |
0.376
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.375
|
|
|
|
nucleosome positioning
|
GO:0016584 |
4 |
0.366
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.365
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.365
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.356
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.339
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.339
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.334
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.321
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.319
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.314
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.311
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.308
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.308
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.305
|
|
|
|
dna hypermethylation
|
GO:0044026 |
3 |
0.300
|
|
|
|
heterochromatin organization
|
GO:0070828 |
4 |
0.298
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.291
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.290
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.281
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.281
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.274
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.273
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.273
|
Fly |
|
|
dna templated transcription termination
|
GO:0006353 |
4 |
0.272
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.252
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.250
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.247
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.245
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
47 |
0.242
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.239
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.238
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.238
|
|
|
|
negative regulation of retinoic acid receptor signaling pathway
|
GO:0048387 |
5 |
0.237
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
56 |
0.233
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.231
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.229
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.225
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
31 |
0.225
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.220
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.220
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.212
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.211
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.209
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.206
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.199
|
|
|
|
rna localization
|
GO:0006403 |
23 |
0.198
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.198
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.191
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
39 |
0.189
|
|
|
|
negative regulation of histone modification
|
GO:0031057 |
18 |
0.189
|
|
|
|
positive regulation of dna templated transcription initiation
|
GO:2000144 |
5 |
0.185
|
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
49 |
0.184
|
|
|
|
negative regulation of dna replication
|
GO:0008156 |
4 |
0.180
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.180
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.179
|
|
|
|
dna replication independent nucleosome assembly
|
GO:0006336 |
1 |
0.176
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.172
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.172
|
|
|
|
negative regulation of histone h3 k9 methylation
|
GO:0051573 |
4 |
0.172
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.170
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.170
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.170
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.168
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.166
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.165
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.165
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.162
|
|
|
|
dna replication
|
GO:0006260 |
52 |
0.158
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.156
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.155
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.153
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.152
|
|
|
|
mitotic chromosome condensation
|
GO:0007076 |
1 |
0.150
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.149
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.149
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.149
|
|
|
|
mrna transport
|
GO:0051028 |
13 |
0.148
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.148
|
|
|
|
regulation of dna replication
|
GO:0006275 |
17 |
0.148
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.147
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.140
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.138
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.136
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.135
|
|
|
|
nucleosome assembly
|
GO:0006334 |
7 |
0.134
|
|
|
|
regulation of transcription by chromatin organization
|
GO:0034401 |
0 |
0.134
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.131
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.130
|
|
|
|
dna conformation change
|
GO:0071103 |
37 |
0.128
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.128
|
|
|
|
dna templated transcription elongation
|
GO:0006354 |
13 |
0.127
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.125
|
|
|
|
negative regulation of transcription elongation from rna polymerase ii promoter
|
GO:0034244 |
6 |
0.124
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.124
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.123
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.123
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.118
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.117
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.116
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.112
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.112
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.110
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.110
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.110
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.109
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.107
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.107
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.103
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.103
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.103
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.102
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.102
|
|
|
|
double strand break repair
|
GO:0006302 |
48 |
0.101
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.101
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.100
|
|
|
|
cellular response to radiation
|
GO:0071478 |
28 |
0.100
|
|
|
|
microtubule organizing center organization
|
GO:0031023 |
28 |
0.098
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.098
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.097
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.096
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.094
|
|
|
|
mitotic sister chromatid segregation
|
GO:0000070 |
14 |
0.093
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.092
|
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.090
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.090
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.089
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.088
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.088
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.087
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.087
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.086
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.085
|
|
|
|
eye photoreceptor cell differentiation
|
GO:0001754 |
41 |
0.085
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.085
|
|
|
|
regulation of synapse structural plasticity
|
GO:0051823 |
4 |
0.085
|
|
|
|
dna templated transcription initiation
|
GO:0006352 |
13 |
0.084
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.083
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.083
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.083
|
|
|
|
oocyte development
|
GO:0048599 |
33 |
0.081
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
42 |
0.081
|
Fly |
|
|
negative regulation of dna templated transcription elongation
|
GO:0032785 |
6 |
0.081
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.080
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.080
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.079
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.078
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.077
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.076
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.076
|
|
|
|
regulation of postsynaptic membrane potential
|
GO:0060078 |
48 |
0.075
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.075
|
|
|
|
embryonic digestive tract development
|
GO:0048566 |
27 |
0.075
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.073
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.073
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.073
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.072
|
|
|
|
rna 3 end processing
|
GO:0031123 |
20 |
0.071
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.071
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
35 |
0.071
|
|
|
|
regulation of skeletal muscle contraction
|
GO:0014819 |
3 |
0.070
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.070
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.069
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.068
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.068
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.067
|
|
|
|
extrinsic apoptotic signaling pathway via death domain receptors
|
GO:0008625 |
34 |
0.067
|
|
|
|
termination of rna polymerase i transcription
|
GO:0006363 |
2 |
0.067
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.067
|
|
|
|
endonucleolytic cleavage involved in rrna processing
|
GO:0000478 |
1 |
0.067
|
|
|
|
transcription elongation from rna polymerase ii promoter
|
GO:0006368 |
9 |
0.067
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.066
|
|
|
|
mitotic sister chromatid cohesion
|
GO:0007064 |
1 |
0.066
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.066
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.065
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.065
|
|
|
|
macromolecule deacylation
|
GO:0098732 |
37 |
0.064
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.064
|
|
|
|
chromatin assembly or disassembly
|
GO:0006333 |
16 |
0.064
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.064
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.063
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.063
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.063
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.062
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.062
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.062
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.062
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.062
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.061
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.060
|
|
|
|
translation
|
GO:0006412 |
93 |
0.060
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.060
|
|
|
|
negative regulation of fatty acid metabolic process
|
GO:0045922 |
10 |
0.060
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.059
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.059
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.059
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.059
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.059
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.058
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.058
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.058
|
|
|
|
centrosome organization
|
GO:0051297 |
26 |
0.057
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.057
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.056
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.056
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.056
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.056
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.056
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.056
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.056
|
|
|
|
response to alkaloid
|
GO:0043279 |
34 |
0.055
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.055
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.055
|
|
|
|
telomere maintenance
|
GO:0000723 |
19 |
0.054
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.054
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.053
|
|
|
|
chromatin silencing at rdna
|
GO:0000183 |
3 |
0.053
|
|
|
|
establishment of rna localization
|
GO:0051236 |
18 |
0.053
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.052
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
36 |
0.052
|
|
|
|
response to osmotic stress
|
GO:0006970 |
21 |
0.051
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.051
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.051
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.050
|
|
|
|
rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0051123 |
3 |
0.050
|
|
|
|
response to hydrogen peroxide
|
GO:0042542 |
32 |
0.050
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.050
|
|
|
|
cellular response to gamma radiation
|
GO:0071480 |
4 |
0.050
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.050
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.049
|
|
|
|
germ line stem cell division
|
GO:0042078 |
2 |
0.049
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.048
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.048
|
|
|
|
maintenance of protein location in nucleus
|
GO:0051457 |
2 |
0.048
|
|
|
|
negative regulation of striated muscle cell differentiation
|
GO:0051154 |
14 |
0.047
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.047
|
|
|
|
regulation of transcription elongation from rna polymerase ii promoter
|
GO:0034243 |
9 |
0.047
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.046
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.045
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.045
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.045
|
|
|
|
positive regulation of stem cell differentiation
|
GO:2000738 |
23 |
0.045
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.045
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.044
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.044
|
|
|
|
histone mrna metabolic process
|
GO:0008334 |
3 |
0.043
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.043
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.043
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.043
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.043
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.043
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.043
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.042
|
|
|
|
rna splicing
|
GO:0008380 |
54 |
0.042
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.042
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.042
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.041
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.041
|
|
|
|
regulation of metaphase anaphase transition of cell cycle
|
GO:1902099 |
9 |
0.040
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.040
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.040
|
|
|
|
mitotic g2 dna damage checkpoint
|
GO:0007095 |
8 |
0.040
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.040
|
|
|
|
protein modification by small protein removal
|
GO:0070646 |
21 |
0.040
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.039
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.039
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.039
|
|
|
|
regulation of mrna processing
|
GO:0050684 |
41 |
0.039
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.038
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.038
|
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
34 |
0.038
|
|
|
|
negative regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903051 |
22 |
0.038
|
|
|
|
regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032434 |
40 |
0.038
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.038
|
|
|
|
dna endoreduplication
|
GO:0042023 |
4 |
0.038
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.038
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.037
|
|
|
|
nucleus localization
|
GO:0051647 |
20 |
0.036
|
|
|
|
regulation of b cell proliferation
|
GO:0030888 |
39 |
0.036
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.036
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.036
|
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
43 |
0.036
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.035
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.035
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.035
|
|
|
|
response to caffeine
|
GO:0031000 |
6 |
0.035
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.035
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.034
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.034
|
|
|
|
protein deacylation
|
GO:0035601 |
36 |
0.034
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.034
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.034
|
|
|
|
negative regulation of protein catabolic process
|
GO:0042177 |
36 |
0.034
|
|
|
|
regulation of dna templated transcription initiation
|
GO:2000142 |
7 |
0.033
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.033
|
|
|
|
rna polyadenylation
|
GO:0043631 |
6 |
0.033
|
|
|
|
protein deacetylation
|
GO:0006476 |
32 |
0.033
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.033
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.032
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
11 |
0.032
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.032
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.032
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.032
|
|
|
|
regulation of histone h3 k4 methylation
|
GO:0051569 |
12 |
0.032
|
|
|
|
ribonucleoprotein complex localization
|
GO:0071166 |
1 |
0.032
|
|
|
|
cell aging
|
GO:0007569 |
35 |
0.031
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.031
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.031
|
|
|
|
mrna 3 end processing
|
GO:0031124 |
16 |
0.031
|
|
|
|
maturation of 5 8s rrna from tricistronic rrna transcript ssu rrna 5 8s rrna lsu rrna
|
GO:0000466 |
1 |
0.030
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.030
|
|
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.030
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.029
|
|
|
|
dna dependent dna replication
|
GO:0006261 |
24 |
0.029
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.029
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.029
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.029
|
|
|
|
regulation of histone acetylation
|
GO:0035065 |
19 |
0.029
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
24 |
0.029
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.028
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.028
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.028
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.028
|
|
|
|
cerebellar cortex development
|
GO:0021695 |
48 |
0.028
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.028
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.028
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.028
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.028
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
48 |
0.028
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.028
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.028
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.027
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.027
|
|
|
|
chromosome organization involved in meiosis
|
GO:0070192 |
39 |
0.027
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.027
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.027
|
|
|
|
positive regulation of cell cycle phase transition
|
GO:1901989 |
17 |
0.027
|
|
|
|
dna catabolic process
|
GO:0006308 |
19 |
0.027
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.027
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.026
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.026
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.026
|
|
|
|
regulation of retinoic acid receptor signaling pathway
|
GO:0048385 |
7 |
0.026
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
34 |
0.026
|
|
|
|
nucleus organization
|
GO:0006997 |
45 |
0.026
|
|
|
|
defense response to fungus
|
GO:0050832 |
12 |
0.026
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.026
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.026
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.026
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.026
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
47 |
0.026
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.025
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.025
|
|
|
|
response to estrogen
|
GO:0043627 |
24 |
0.025
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.025
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.025
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.024
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.024
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.024
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.024
|
|
|
|
ribonucleoprotein complex subunit organization
|
GO:0071826 |
28 |
0.024
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.024
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.024
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.024
|
|
|
|
positive regulation of g1 s transition of mitotic cell cycle
|
GO:1900087 |
9 |
0.024
|
|
|
|
microtubule sliding
|
GO:0051012 |
1 |
0.024
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.023
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.023
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.023
|
|
|
|
endonucleolytic cleavage of tricistronic rrna transcript ssu rrna 5 8s rrna lsu rrna
|
GO:0000479 |
1 |
0.023
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.023
|
|
|
|
negative regulation of epidermal cell differentiation
|
GO:0045605 |
7 |
0.023
|
|
|
|
dna dependent dna replication maintenance of fidelity
|
GO:0045005 |
3 |
0.023
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.023
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.023
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.023
|
|
|
|
nucleobase containing compound transport
|
GO:0015931 |
27 |
0.023
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.023
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.022
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.022
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.022
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.022
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.022
|
|
|
|
transcription initiation from rna polymerase ii promoter
|
GO:0006367 |
8 |
0.022
|
|
|
|
peptidyl lysine methylation
|
GO:0018022 |
29 |
0.022
|
|
|
|
histone h3 acetylation
|
GO:0043966 |
14 |
0.022
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.022
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.022
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.021
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.021
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.021
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.021
|
|
|
|
response to purine containing compound
|
GO:0014074 |
28 |
0.021
|
|
|
|
protein localization to chromatin
|
GO:0071168 |
3 |
0.021
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.021
|
|
|
|
maternal process involved in female pregnancy
|
GO:0060135 |
32 |
0.021
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.021
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.021
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
43 |
0.021
|
|